The purpose of Cancer News is to provide summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world.
Original news summaries from peer-reviewed journals and
oncology meetings are provided daily.
News by Cancer Type
We have categorized our cancer news articles by disease type.
Please select a topic from the drop down list below for more information on
that topic.
Latest Cancer News
Nexavar® Effective for Refractory Thyroid Cancer(8/19/2008) Researchers from the University of Pennsylvania have reported that Nexavar® (sorafenib) has significant activity for the treatment of metastatic iodine-refractory thyroid cancer. The details of this study were reported in an early online paper in the Journal of Clinical Oncology on June 9, 2008.
New Study Confirms Increased Incidence of Adenocarcinoma of the Esophagus in White Americans(8/19/2008) Researchers from the National Institutes of Health (NIH) have reported that between 1975 and 2004, the incidence of adenocarcinoma of the esophagus increased by 463% in White males and 335% in White females. The details of this study appeared in an early online publication in the Journal of the National Cancer Institute on August 11, 2008.
Physical Activity Decreases Risk of Developing Cancer in Japanese Men and Women(8/15/2008) Researchers from Japan have reported that increased daily physical activity decreases the risk of cancer development in a “relatively lean population”. The details of this study appeared in the August 15, 2008 issue of the American Journal of Epidemiology.
Will Intra-osseous Injection of Umbilical Cord Blood Reduce Graft Failures?(8/15/2008) Researchers from Italy have reported that the injection of umbilical cord blood directly into the pelvic bones of patients with leukemia appears promising. These results were recently published in an early online publication of the Lancet Oncology on August 9, 2008.
More Fruits and Veggies, Less Meat Reduces Colorectal Cancer(8/14/2008) Researchers affiliated with the NIH-AARP Diet and Health Study have reported that individuals who consume a diet that is rich in vegetables, fruits, whole grains, and healthy oils, contains sufficient dietary calcium and vitamin D, and is low in solid fats, added sugar, and red meats have a significantly reduced risk of developing colorectal cancer. These results were recently published in the July 1, 2008 issue of the American Journal of Epidemiology.
Sutent® Provides Superior Quality of Life Compared with Interferon in Kidney Cancer(8/14/2008) The targeted agent Sutent® (sunitinib) provides superior quality of life compared with interferon alfa for patients with advanced renal cell carcinoma (RCC). These results were recently published in the August 1, 208 issue of Journal of Clinical Oncology.
Prophylactic Dental Care Reduces Risk of Bisphosphonate-induced Osteonecrosis of the Jaw(8/12/2008) Researchers from Italy have reported that preventive dental measures reduced the risk of osteonecrosis of the jaw associated with bisphosphonate therapy from 3.2% to 1.3%. The details of this study appeared in an early online publication in the Annals of Oncology on July 22, 2008.
Avastin® plus Reduced-dose Interferon Effective for Metastatic Renal Cell Carcinoma(8/12/2008) Researchers affiliated with a multicenter international trial have reported that the addition of Avastin® (bevacizumab) to reduced doses of interferon improves progression-free survival of patients with metastatic renal cell carcinoma. The details of this study appeared in the August 2008 issue of the Annals of Oncology.
Adjuvant Chemotherapy Does Not Adversely Affect Quality of Life of Elderly Patients with Colorectal Cancer(8/11/2008) Researchers from France have reported that patients 75 years of age or older with Stage III colon or rectal cancer receiving adjuvant chemotherapy or radiotherapy did not have negative effects on quality-of-life parameters compared with patients not receiving adjuvant therapy. The details of this study appeared in the August 15, 2008 issue of Cancer.
Neulasta® Deemed Cost-effective for Prevention of Febrile Neutropenia(8/11/2008) Researchers from the University of Rochester have reported that prophylactic Neulasta® (pegfilgrastim) is cost-effective when compared with no G-CSF or with Neupogen® (filgrastim). The details of this study appeared in the March-April 2008 issue of Value Health.
Prophylactic Neulasta® After Cycle One of Chemotherapy Superior to Later Use In Elderly Patients(8/8/2008) Researchers from the H. Lee Moffitt Cancer Center have reported that the prophylactic (proactive) administration Neulasta® (pegfilgrastim) decreased febrile neutropenia and related events in elderly patients with cancer receiving mild to moderately neutropenic chemotherapy. The details of this study appeared in the December 2007 issue of Oncologist.
ReMission™ Video Game Improves Treatment Adherence and Knowledge Among Pediatric Cancer Patients(8/8/2008) Researchers from the United States, Canada, and Australia have reported that the video game ReMission™, whose main character is a robot fighting cancer cells, improves treatment adherence, cancer-related self-efficacy, and knowledge among pediatric cancer patients. These results were recently published in the August 1, 2008 issue of Pediatrics.
Primary Prophylaxis with Neulasta® Deemed Cost-effective in Early-stage Breast Cancer(8/7/2008) Researchers from the Fred Hutchinson Cancer Research Center have reported that primary Neulasta® (pegfilgrastim) prophylaxis for patients with early-stage breast cancer is cost-effective compared with secondary prophylaxis. The details of this study appeared in an early online publication in Value Health on July 31, 2008.
Management of Colonoscopic Perforations Described(8/7/2008) Researchers from the Mayo Clinic have reported that “Colonoscopic perforation occurs in fewer than 1 in 1000 patients and is associated with significant morbidity and mortality.” The details of this retrospective review were published in the July 2008 issue of the Archives of Surgery.
Single-dose Neulasta® Effective for Mobilization of Peripheral Blood Stem Cells in Children(8/6/2008) Researchers from Italy have reported that single-dose Neulasta® (pegfilgrastim) in conjunction with chemotherapy was effective for harvesting peripheral blood stem cells (PBSC) in children with poor-risk malignancies. The details of this study were published in an early online publication in Bone Marrow Transplantation on July 21, 2008.
U.S. Preventive Service Task Force Does Not Recommend PSA Screening for Prostate Cancer(8/6/2008) Members of the U.S. Preventive Services Task Force have concluded that there is still insufficient evidence to recommend PSA screening in men 75 years of age or younger. The details of these recommendations were published in the August 5, 2008 issue of the Annals of Internal Medicine.
Prophylactic Neulasta® Reduces Febrile Neutropenia and Early Deaths Among Patients Receiving Chemotherapy(8/5/2008) Researchers from the University of Rochester, the University of Washington, and Duke University have reported that prophylactic use of Neulasta® (pegfilgrastim) among cancer patients receiving chemotherapy reduces the risk of developing febrile neutropenia and early death. These results were recently published in the July 20, 2007 issue of the Journal of Clinical Oncology.
Para-aortic Node Dissection for Gastric Cancer Does Not Improve Survival(8/5/2008) Researchers from Japan have reported that D2 node dissection plus para-aortic node dissection does not improve survival of patients with T2b, T3, or T4 gastric cancer compared with D2 node dissection alone. The details of this study appeared in the July 31, 2008 issue of the New England Journal of Medicine.
Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers(8/4/2008) Researchers affiliated with the Cancer Programs, American College of Surgeons, recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. The results of this study were published in the July 2008 issue of the Archives of Surgery.
Patient Home
